Section XI Financial Report
Total Page:16
File Type:pdf, Size:1020Kb
Section XI Financial Report I. Auditor’s Report Has the semi-annual report been audited □ Yes √ No The Company's semi-annual financial report has not been audited. II. Financial statements The unit of the figures in the statements in the notes to the financial statements: yuan 1 Consolidated balance sheet Prepared by Meinian Onehealth Healthcare Holdings Co., Ltd. as at 30 June 2020 Expressed in Renminbi Yuan Item 30 June 2020 31 December 2019 Current assets Cash at bank and on hand 2,514,532,837.26 4,759,517,528.74 Settlement funds Lendings to banks and other financial institutions Financial assets held for trading Derivative financial assets Bills receivable 1,339,476.00 1,960,000.00 Accounts receivable 2,130,943,760.87 2,292,574,441.06 Receivables under financing Prepayments 224,710,369.31 214,342,103.57 Premium receivable Reinsurance receivables Reinsurance contract provisions receivable Other receivables 499,351,220.08 384,677,621.78 Including: Interest receivable 615,073.84 738,823.84 Dividends receivable 39,725,570.73 25,339,452.03 Financial assets purchased under reverse sale agreements Inventories 119,878,893.35 129,615,381.32 Contract assets Assets held for sale Non-current assets due within one year 583,312,924.83 653,333,835.18 Other current assets 212,997,434.56 255,395,925.36 Total current assets 6,287,066,916.26 8,691,416,837.01 Non-current assets Loans and advances to customers Debt investments Other debt investments Long-term receivables 633,467,537.08 828,318,900.01 1 Long-term equity investments 157,013,371.17 162,090,985.54 Investments in other equity instruments Other non-current financial assets 1,271,876,037.72 1,226,749,518.89 Investment properties Fixed assets 2,472,855,083.89 2,608,356,009.29 Construction in progress 82,974,642.29 59,483,859.71 Bearer biological assets Oil and gas assets Right-of-use assets Intangible assets 166,328,353.26 163,907,170.30 Development costs Goodwill 4,206,110,762.59 4,104,391,143.02 Long-term deferred expenses 662,587,897.28 736,398,352.65 Deferred tax assets 343,919,454.73 100,159,632.69 Other non-current assets 558,947,952.32 237,348,067.10 Total non-current assets 10,556,081,092.33 10,227,203,639.20 Total assets 16,843,148,008.59 18,918,620,476.21 Current liabilities Short-term loans 2,041,260,631.04 2,309,069,932.12 Borrowings from the central bank Loans from banks and other financial institutions Financial liabilities held for trading Derivative financial liabilities Bills payable 16,050,200.00 636,592.00 Accounts payable 838,893,632.39 862,957,946.40 Advance payments received 1,447,485,391.71 Contract liabilities 1,393,741,279.29 Financial assets sold under repurchase agreements Accepted deposits and deposits from banks Securities brokerage Securities underwriting brokerage Employee benefits payable 416,098,437.48 457,112,710.77 Taxes payable 40,705,218.97 200,243,964.38 Other payables 340,386,828.45 389,436,292.94 Including: Interest payable Dividends payable 5,790,503.84 7,767,421.57 Fee and commission payable Reinsurance payables Liabilities held for sale Non-current liabilities due within one year 2,585,366,100.38 2,316,036,316.81 Other current liabilities Total current liabilities 7,672,502,328.00 7,982,979,147.13 Non-current liabilities Provisions for insurance contracts Long-term loans 1,547,887,089.36 1,182,789,431.02 Debentures payable 1,367,746,765.24 Including: Preference shares Perpetual bonds Lease liabilities Long-term payables 167,738,668.81 217,928,737.12 2 Long-term employee benefits payable Provisions Deferred income 15,836,502.03 8,183,333.33 Deferred tax liabilities 5,228,765.52 3,957,992.89 Other non-current liabilities 1,541,009.17 1,013,418.15 Total non-current liabilities 1,738,232,034.89 2,781,619,677.75 Total liabilities 9,410,734,362.89 10,764,598,824.88 Owners’ equity Share capital 3,919,920,974.00 3,919,920,974.00 Other equity instruments Including: Preference shares Perpetual bonds Capital reserve 2,511,924,578.99 2,439,936,041.00 Less: Treasury shares 300,055,044.16 300,055,044.16 Other comprehensive income -1,720,319.06 -379,371.01 Specific reserve Surplus reserve 71,934,339.69 71,934,339.69 General risk reserve Retained earnings 401,890,576.85 1,184,276,684.09 Total equity attributable to owners of the Company 6,603,895,106.31 7,315,633,623.61 Non-controlling interests 828,518,539.39 838,388,027.72 Total owners’ equity 7,432,413,645.70 8,154,021,651.33 Total liabilities and owners’ equity 16,843,148,008.59 18,918,620,476.21 Legal Representative: Yu Rong The person in charge of accounting The head of the accounting affairs: Ya Zhigao department: Ya Zhigao 2 Company balance sheet Expressed in Renminbi Yuan Item 30 June 2020 31 December 2019 Current assets Cash at bank and on hand 655,124,987.41 1,641,522,730.76 Financial assets held for trading Derivative financial assets Bills receivable Accounts receivable 10,100,000.00 41,100,000.00 Receivables under financing Prepayments 7,720,791.19 5,325,113.47 Other receivables 425,422,099.81 280,176,115.49 Including: Interest receivable Dividends receivable 39,725,570.73 125,339,452.03 Inventories 80,275.41 99,547.38 Contract assets Assets held for sale Non-current assets due within one year Other current assets 16,270,274.95 14,582,000.90 Total current assets 1,114,718,428.77 1,982,805,508.00 Non-current assets 3 Debt investments Other debt investments Long-term receivables Long-term equity investments 9,681,662,348.57 9,680,902,711.89 Investments in other equity instruments Other non-current financial assets 440,191,147.62 466,288,823.14 Investment properties Fixed assets 2,333,953.53 2,969,362.51 Construction in progress Bearer biological assets Oil and gas assets Right-of-use assets Intangible assets Development costs Goodwill Long-term deferred expenses 9,019,826.10 10,105,733.60 Deferred tax assets Other non-current assets 100,640,000.00 100,640,000.00 Total non-current assets 10,233,847,275.82 10,260,906,631.14 Total assets 11,348,565,704.59 12,243,712,139.14 Current liabilities Short-term loans Financial liabilities held for trading Derivative financial liabilities Bills payable Accounts payable 3,860,921.45 2,581,565.16 Advance payments received Contract liabilities Employee benefits payable 1,534,739.19 6,292,870.59 Taxes payable 349,775.30 795,932.88 Other payables 1,191,158,631.17 1,164,582,227.11 Including: Interest payable Dividends payable Liabilities held for sale Non-current liabilities due within one year 20,031,930.56 959,903,895.89 Other current liabilities Total current liabilities 1,216,935,997.67 2,134,156,491.63 Non-current liabilities Long-term loans Debentures payable Including: Preference shares Perpetual bonds Lease liabilities Long-term payables 688,300.00 Long-term employee benefits payable Provisions Deferred income Deferred tax liabilities Other non-current liabilities Total non-current liabilities 688,300.00 4 Total liabilities 1,217,624,297.67 2,134,156,491.63 Owners’ equity Share capital 3,919,920,974.00 3,919,920,974.00 Other equity instruments Including: Preference shares Perpetual bonds Capital reserve 6,326,571,718.36 6,254,583,180.37 Less: Treasury shares 300,055,044.16 300,055,044.16 Other comprehensive income Specific reserve Surplus reserve 136,626,800.32 136,626,800.32 Retained earnings 47,876,958.40 98,479,736.98 Total owners’ equity 10,130,941,406.92 10,109,555,647.51 Total liabilities and owners’ equity 11,348,565,704.59 12,243,712,139.14 3 Consolidated income statement Expressed in Renminbi Yuan Six months of Six months of Item 2020 2019 I. Total operating income 1,814,450,825.76 3,641,060,666.52 Including: Operating income 1,814,450,825.76 3,641,060,666.52 Interest income Earned premium Fee and commission income II. Total operating costs 2,876,381,912.93 3,779,806,068.31 Including: Operating costs 1,732,974,753.43 2,344,165,299.69 Interest expense Fee and commission expenses Surrender value Net amount of compensation expenses Net amount of appropriation to insurance reserves Policy dividend payment Commissions for reinsurance Taxes and surcharges 2,247,622.21 6,223,834.77 Selling and distribution expenses 669,364,221.05 910,302,583.50 General and administrative expenses 245,100,703.39 308,565,538.54 Research and development expenses 17,647,421.12 22,964,101.21 Financial expenses 209,047,191.73 187,584,710.60 Including: Interest expenses 204,797,359.52 197,564,525.14 Interest income 19,911,737.88 12,710,587.25 Add: Other income 11,367,669.24 2,147,648.83 Investment income (“-” for losses) 69,637,371.28 41,037,273.03 Including: Income from investment in associates and joint ventures -5,385,777.78 -3,672,776.99 Income arising from derecognition of financial assets measured at amortised cost Exchange gains (“-” for losses) Gains from the net exposure hedge (“-” for losses) 5 Gains from changes in fair value (“-” for losses) 7,355,571.02 183,835,590.00 Credit losses (“-” for losses) -59,220,725.12 -8,527,923.80 Impairment losses (“-” for losses) Gains from asset disposals (“-” for losses) -1,260,186.25 -497,308.27 III.